|6th November 2020||Stephen P Ewald||10,518||Exercise of derivative||$14.41||$151,564.38|
|8th October 2020||Susan E Burwig||20,000||Exercise of derivative||$14.41||$288,200.00|
|6th October 2020||August J. Troendle||50,000||Exercise of derivative||$23.00||$1,150,000.00|
|5th October 2020||August J. Troendle||2,592||Exercise of derivative||$16.20||$41,990.40|
|5th October 2020||August J. Troendle||1,851||Exercise of derivative||$14.41||$26,672.91|
|5th October 2020||Investors, Llc Medpace||2,592||Exercise of derivative||$16.20||$41,990.40|
|5th October 2020||Investors, Llc Medpace||1,851||Exercise of derivative||$14.41||$26,672.91|
|1st September 2020||Jesse J Geiger||3,110||Open or private sale||$130.00||$404,300.00|
|1st September 2020||Jesse J Geiger||3,110||Exercise of derivative||$23.00||$71,530.00|
|31st August 2020||Jesse J Geiger||3,700||Exercise of derivative||$23.00||$85,100.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 3/10.
Medpace Holdings, Inc. provides outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.